Product Focus: PAXLOVID

January 4, 2022

PAXLOVID – Oral Antiviral Treatment for COVID-19 The FDA has recently granted emergency use authorization (EUA) for PAXLOVID. Paxlovid is nirmatrelvir tablets co-packaged with ritonavir tablets, both antiviral agents. Both agents must be administered together. In clinical trials, PAXLOVID significantly reduced the risk of hospitalization or death for any cause by 89% compared to placebo…